- Home
- MYGN vs CLNE Comparison
MYGN vs CLNE Comparison
Compare MYGN & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- CLNE
- Stock Information
- Founded
- MYGN 1991
- CLNE 2001
- Country
- MYGN United States
- CLNE United States
- Employees
- MYGN N/A
- CLNE N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CLNE Natural Gas Distribution
- Sector
- MYGN Health Care
- CLNE Utilities
- Exchange
- MYGN Nasdaq
- CLNE Nasdaq
- Market Cap
- MYGN 744.7M
- CLNE 610.0M
- IPO Year
- MYGN 1995
- CLNE 2007
- Fundamental
- Price
- MYGN $7.29
- CLNE $1.41
- Analyst Decision
- MYGN Hold
- CLNE Strong Buy
- Analyst Count
- MYGN 16
- CLNE 3
- Target Price
- MYGN $20.17
- CLNE $4.00
- AVG Volume (30 Days)
- MYGN 1.2M
- CLNE 2.7M
- Earning Date
- MYGN 05-06-2025
- CLNE 05-08-2025
- Dividend Yield
- MYGN N/A
- CLNE N/A
- EPS Growth
- MYGN N/A
- CLNE N/A
- EPS
- MYGN N/A
- CLNE N/A
- Revenue
- MYGN $837,600,000.00
- CLNE $415,865,000.00
- Revenue This Year
- MYGN $2.99
- CLNE N/A
- Revenue Next Year
- MYGN $8.36
- CLNE $13.08
- P/E Ratio
- MYGN N/A
- CLNE N/A
- Revenue Growth
- MYGN 11.21
- CLNE N/A
- 52 Week Low
- MYGN $7.35
- CLNE $1.30
- 52 Week High
- MYGN $29.30
- CLNE $3.67
- Technical
- Relative Strength Index (RSI)
- MYGN 25.95
- CLNE 40.16
- Support Level
- MYGN $7.69
- CLNE $1.32
- Resistance Level
- MYGN $8.27
- CLNE $1.54
- Average True Range (ATR)
- MYGN 0.56
- CLNE 0.13
- MACD
- MYGN 0.02
- CLNE 0.03
- Stochastic Oscillator
- MYGN 1.02
- CLNE 36.67
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About CLNE Clean Energy Fuels Corp.
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas, and renewable natural gas as an alternative fuel for vehicles. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.